Log in

NASDAQ:PAHC - Phibro Animal Health Stock Price, Forecast & News

$20.26
+0.24 (+1.20 %)
(As of 03/29/2020 04:44 AM ET)
Today's Range
$18.44
Now: $20.26
$20.59
50-Day Range
$17.75
MA: $24.21
$27.53
52-Week Range
$16.87
Now: $20.26
$36.98
Volume238,023 shs
Average Volume224,307 shs
Market Capitalization$819.52 million
P/E Ratio21.55
Dividend Yield2.40%
Beta0.43
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It also operates in Israel, Latin America, Canada, Europe, Africa, and the Asia/Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. The company is headquartered in Teaneck, New Jersey. Phibro Animal Health Corporation is a subsidiary of BFI Co., LLC.
Read More
Phibro Animal Health logo

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PAHC
CUSIPN/A
Phone201-329-7300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$828 million
Cash Flow$2.26 per share
Book Value$5.34 per share

Profitability

Net Income$54.71 million

Miscellaneous

Employees1,600
Market Cap$819.52 million
Next Earnings Date5/4/2020 (Estimated)
OptionableOptionable

Receive PAHC News and Ratings via Email

Sign-up to receive the latest news and ratings for PAHC and its competitors with MarketBeat's FREE daily newsletter.


Phibro Animal Health (NASDAQ:PAHC) Frequently Asked Questions

How has Phibro Animal Health's stock been impacted by COVID-19 (Coronavirus)?

Phibro Animal Health's stock was trading at $24.58 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PAHC shares have decreased by 17.6% and is now trading at $20.26. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Phibro Animal Health?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last year. There are currently 1 sell rating and 5 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Phibro Animal Health.

When is Phibro Animal Health's next earnings date?

Phibro Animal Health is scheduled to release its next quarterly earnings announcement on Monday, May 4th 2020. View our earnings forecast for Phibro Animal Health.

How were Phibro Animal Health's earnings last quarter?

Phibro Animal Health Corp (NASDAQ:PAHC) posted its quarterly earnings data on Monday, February, 3rd. The company reported $0.34 earnings per share for the quarter, beating analysts' consensus estimates of $0.28 by $0.06. The business earned $214 million during the quarter, compared to analyst estimates of $218.87 million. Phibro Animal Health had a net margin of 4.67% and a return on equity of 23.94%. The business's revenue was down 1.9% compared to the same quarter last year. During the same period last year, the firm earned $0.41 EPS. View Phibro Animal Health's earnings history.

How often does Phibro Animal Health pay dividends? What is the dividend yield for Phibro Animal Health?

Phibro Animal Health announced a quarterly dividend on Monday, February 3rd. Stockholders of record on Wednesday, March 4th will be given a dividend of $0.12 per share on Wednesday, March 25th. This represents a $0.48 annualized dividend and a yield of 2.37%. The ex-dividend date is Tuesday, March 3rd. View Phibro Animal Health's dividend history.

What guidance has Phibro Animal Health issued on next quarter's earnings?

Phibro Animal Health issued an update on its FY20 earnings guidance on Monday, February, 3rd. The company provided EPS guidance of $1.15-1.22 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.11. The company issued revenue guidance of $812-828 million, compared to the consensus revenue estimate of $838.36 million.

What price target have analysts set for PAHC?

6 brokers have issued 12 month price objectives for Phibro Animal Health's shares. Their forecasts range from $18.00 to $30.00. On average, they anticipate Phibro Animal Health's share price to reach $25.20 in the next year. This suggests a possible upside of 24.4% from the stock's current price. View analysts' price targets for Phibro Animal Health.

Has Phibro Animal Health been receiving favorable news coverage?

Media coverage about PAHC stock has been trending somewhat positive recently, InfoTrie Sentiment reports. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Phibro Animal Health earned a daily sentiment score of 1.2 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutPhibro Animal Health.

Are investors shorting Phibro Animal Health?

Phibro Animal Health saw a increase in short interest in the month of March. As of March 13th, there was short interest totaling 867,200 shares, an increase of 16.3% from the February 27th total of 745,900 shares. Based on an average daily volume of 197,400 shares, the days-to-cover ratio is presently 4.4 days. Currently, 4.3% of the company's stock are sold short. View Phibro Animal Health's Current Options Chain.

Who are some of Phibro Animal Health's key competitors?

What other stocks do shareholders of Phibro Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Intercept Pharmaceuticals (ICPT), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Zoetis (ZTS), Booking (BKNG), Banco Bradesco (BBD) and Gilead Sciences (GILD).

Who are Phibro Animal Health's key executives?

Phibro Animal Health's management team includes the following people:
  • Mr. Jack Clifford Bendheim, Chairman, Pres & CEO (Age 72)
  • Mr. Larry L. Miller, Chief Operating Officer (Age 55)
  • Mr. Dean J. Warras, Pres of Animal Health & Nutrition - North America (Age 50)
  • Mr. Richard G. Johnson, Chief Financial Officer (Age 70)
  • Mr. Thomas G. Dagger, Sr. VP, Gen. Counsel & Corp. Sec. (Age 61)

What is Phibro Animal Health's stock symbol?

Phibro Animal Health trades on the NASDAQ under the ticker symbol "PAHC."

Who are Phibro Animal Health's major shareholders?

Phibro Animal Health's stock is owned by a number of retail and institutional investors. Top institutional investors include Janus Henderson Group PLC (2.68%), Principal Financial Group Inc. (2.35%), Renaissance Technologies LLC (2.07%), State Street Corp (1.71%), Cove Street Capital LLC (1.47%) and Eagle Asset Management Inc. (1.16%). Company insiders that own Phibro Animal Health stock include Bfi Co, Llc, Daniel M Bendheim, Dean J Warras, E Thomas Corcoran and Jack Bendheim. View institutional ownership trends for Phibro Animal Health.

Which major investors are selling Phibro Animal Health stock?

PAHC stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Ceredex Value Advisors LLC, Nuveen Asset Management LLC, Acadian Asset Management LLC, Oxford Asset Management LLP, Bank of New York Mellon Corp, Goldman Sachs Group Inc., and AQR Capital Management LLC. View insider buying and selling activity for Phibro Animal Health.

Which major investors are buying Phibro Animal Health stock?

PAHC stock was bought by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Eagle Asset Management Inc., Madison Asset Management LLC, Heartland Advisors Inc., Norges Bank, Martingale Asset Management L P, Raymond James & Associates, and Renaissance Technologies LLC. View insider buying and selling activity for Phibro Animal Health.

How do I buy shares of Phibro Animal Health?

Shares of PAHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Phibro Animal Health's stock price today?

One share of PAHC stock can currently be purchased for approximately $20.26.

How big of a company is Phibro Animal Health?

Phibro Animal Health has a market capitalization of $819.52 million and generates $828 million in revenue each year. The company earns $54.71 million in net income (profit) each year or $1.53 on an earnings per share basis. Phibro Animal Health employs 1,600 workers across the globe. View additional information about Phibro Animal Health.

What is Phibro Animal Health's official website?

The official website for Phibro Animal Health is http://www.pahc.com/.

How can I contact Phibro Animal Health?

Phibro Animal Health's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The company can be reached via phone at 201-329-7300 or via email at [email protected]


MarketBeat Community Rating for Phibro Animal Health (NASDAQ PAHC)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  283 (Vote Outperform)
Underperform Votes:  349 (Vote Underperform)
Total Votes:  632
MarketBeat's community ratings are surveys of what our community members think about Phibro Animal Health and other stocks. Vote "Outperform" if you believe PAHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PAHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel